Practical & legal considerations of deploying AI in the biotech sector – now and future
Tracks
Track 1
Friday, November 1, 2024 |
2:10 PM - 2:55 PM |
Details
AI is proving to be a useful time-saver for many industries, but in terms of discovery, development and ultimately IP ownership in the biotech industry, where are the boundaries and what are the best uses for these developing technologies?
Bringing you AI experts from industry, IP and law, the panel will explore some key discussion points around AI use:
What is AI being used for in the current biotech landscape?
Practical challenges of utilising AI in creating or commercialising inventions
What role can AI play or shape the biotech industry for the next five to ten years?
Positive impacts and/or concerns
Legal challenges associated with protection of AI inventions
Broader legal considerations in using AI
Speaker
Michelle Blyth
Senior Associate
Spruson & Ferguson
Chair
David Hansen
CEO
CSIRO